← Evidence map

ReviewCardiovascular drugs and therapy2022

The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.

Olga Papazisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33085026